|
Feb 20
|
Will TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know
|
|
Feb 20
|
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
|
|
Jan 10
|
TG Therapeutics Reverses Its 225% Winning Streak On Lackluster Guidance
|
|
Jan 10
|
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
|
|
Jan 9
|
Director Laurence Charney Sells 17,500 Shares of TG Therapeutics Inc
|
|
Jan 9
|
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases
|
|
Jan 6
|
Insider Sell: CFO Sean Power Sells 47,867 Shares of TG Therapeutics Inc (TGTX)
|
|
Jan 5
|
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 7
|
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
|
|
Dec 4
|
TG Therapeutics (NASDAQ:TGTX) grows 9.1% this week, taking five-year gains to 170%
|
|
Nov 27
|
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
|
|
Oct 14
|
13 Stocks to Buy with Exponential Growth
|
|
Sep 14
|
TG Therapeutics, Inc.'s (NASDAQ:TGTX) institutional investors lost 8.3% last week but have benefitted from longer-term gains
|
|
Sep 7
|
TG Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
|
|
Sep 6
|
Unraveling the Future of TG Therapeutics Inc (TGTX): A Deep Dive into Key Metrics
|
|
Jul 13
|
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
|
|
Jun 27
|
Despite shrinking by US$188m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 427% over 1 year
|
|
May 2
|
Q1 2023 TG Therapeutics Inc Earnings Call
|
|
May 1
|
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
|
|
May 1
|
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
|